Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 01/07/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1732 publications
Nivolumab plus brentuximab vedotin for relapsed/refractory diffuse large B-cell lymphoma.
Journal: Future oncology (London, England)
Published: December 10, 2025
Primary ALK-Negative Anaplastic Large Cell Lymphoma Mimicking Septic Arthritis in a Diabetic Patient: Diagnostic and Therapeutic Challenges.
Journal: Journal of visualized experiments : JoVE
Published: December 08, 2025
Correction: Genome-wide CRISPR screen identifies MAD2L1BP and ANAPC15 as targets for brentuximab vedotin sensitivity in CD30+ peripheral T-cell lymphoma.
Journal: Leukemia
Published: November 10, 2025
Progress in the Treatment of Advanced-Stage Classical Hodgkin Lymphoma in the PET-Adapted Era.
Journal: Oncology (Williston Park, N.Y.)
Published: October 31, 2025
Pathobiological link between CD30 and abnormal lymphocytes in adult T-cell leukemia/lymphoma.
Journal: Journal of clinical and experimental hematopathology : JCEH
Published: October 29, 2025
Emerging therapeutic strategies for CD30-positive lymphomas.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: October 25, 2025
Non-allergic immediate hypersensitivity to Brentuximab vedotin in pediatrics: usefulness of skin testing to guide provocation testing
Journal: Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)
Published: October 02, 2025
What's new about cutaneous T-cell lymphoma?
Journal: Therapeutische Umschau. Revue therapeutique
Published: October 01, 2025
Treatment strategy for classical Hodgkin lymphoma and future perspectives
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: October 01, 2025
Brentuximab Vedotin With Adriamycin, Vinblastine, and Dacarbazine for Patients Aged 18-59 Years With Untreated Advanced Stage Classical Hodgkin Lymphoma: The Largest Real-Life Series From Southern Italy Cancer Centers.
Journal: European journal of haematology
Published: September 29, 2025
Extracellular CD30 Regulates Brentuximab Vedotin-Induced Cell Death in an Adult T-Cell Leukemia Cell Line.
Journal: Biological & pharmaceutical bulletin
Published: September 17, 2025
Impact of KMT2A Rearrangement on Peripheral T-Cell Lymphoma, Not Otherwise Specified, and Angioimmunoblastic T-Cell Lymphoma.
Journal: Biomedicines
Published: September 04, 2025
Last Updated: 01/07/2026